{
  "case_id": "Case_2",
  "model_id": "openai/gpt-oss-120b",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Delirium due to hypercalcemia (metabolic)\",\n        \"confidence\": 0.78,\n        \"icd_code\": \"F05.0\",\n        \"reasoning\": \"Acute changes in cognition, hallucinations, weight loss, mild anemia and elevated calcium suggest a metabolic encephalopathy. Hypercalcemia is a known reversible cause of delirium in older adults.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Alzheimer's disease / mixed dementia\",\n            \"confidence\": 0.55,\n            \"icd_code\": \"G30.9\",\n            \"reasoning\": \"Progressive cognitive decline and personality changes over months could represent early dementia; however, the rapid progression, weight loss, and hypercalcemia point more to a secondary cause.\"\n        },\n        {\n            \"name\": \"Major depressive disorder with psychotic features\",\n            \"confidence\": 0.40,\n            \"icd_code\": \"F33.3\",\n            \"reasoning\": \"Depression in the elderly can present with fatigue, weight loss, and psychosis, but the presence of hypercalcemia and falls makes a primary psychiatric diagnosis less likely.\"\n        },\n        {\n            \"name\": \"Multiple myeloma (or other malignancy causing hypercalcemia)\",\n            \"confidence\": 0.65,\n            \"icd_code\": \"C90.0\",\n            \"reasoning\": \"Weight loss, anemia, hypercalcemia, and new neuropsychiatric symptoms are classic for a plasma\u2011cell disorder or other malignancy producing paraneoplastic hypercalcemia.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Progressive fatigue, 15\u2011lb weight loss, and intermittent confusion over 6 months\",\n        \"Mild anemia, mildly elevated serum calcium, recent falls, hallucinations (talking to deceased husband)\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"Comprehensive metabolic panel with ionized calcium\",\n            \"purpose\": \"Confirm degree of hypercalcemia, assess renal function and electrolyte disturbances\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Serum parathyroid hormone (PTH) level\",\n            \"purpose\": \"Distinguish primary hyperparathyroidism from malignancy\u2011related hypercalcemia\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Serum protein electrophoresis (SPEP) with immunofixation\",\n            \"purpose\": \"Screen for multiple myeloma or other monoclonal gammopathies\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"CT chest/abdomen/pelvis with contrast\",\n            \"purpose\": \"Identify possible malignancy (lung, breast, renal) causing hypercalcemia\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Brain MRI without contrast\",\n            \"purpose\": \"Rule out structural brain lesions contributing to delirium\",\n            \"priority\": \"routine\"\n        },\n        {\n            \"test\": \"Complete blood count with differential\",\n            \"purpose\": \"Assess anemia severity and look for leukocytosis or other abnormalities\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"Thyroid function tests (TSH, free T4)\",\n            \"purpose\": \"Exclude hypothyroidism as a contributor to cognitive change\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Initiate aggressive IV hydration with isotonic saline (2\u20133 L/24\u202fh) to promote calciuresis\",\n            \"Begin IV bisphosphonate (e.g., zoledronic acid 4\u202fmg IV over 15\u202fmin) after confirming renal function\",\n            \"Obtain ECG to assess for QT prolongation or arrhythmias\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Zozo (Zoledronic acid)\",\n                \"dose\": \"4\u202fmg IV single dose\",\n                \"route\": \"IV\",\n                \"duration\": \"Single dose; repeat if calcium remains >12\u202fmg/dL after 48\u202fh\",\n                \"rationale\": \"Inhibits osteoclast-mediated bone resorption, rapidly lowering calcium\"\n            },\n            {\n                \"drug\": \"Calcitriol (active vitamin D)\",\n                \"dose\": \"0.25\u202f\u00b5g PO daily\",\n                \"route\": \"PO\",\n                \"duration\": \"Until calcium normalizes; then reassess\",\n                \"rationale\": \"Used if PTH\u2011mediated hypercalcemia is confirmed\"\n            },\n            {\n                \"drug\": \"Ceftriaxone\",\n                \"dose\": \"1\u202fg IV q24h\",\n                \"route\": \"IV\",\n                \"duration\": \"5\u20117\u202fdays if infection suspected\",\n                \"rationale\": \"Empiric coverage for urinary or pulmonary infection that could precipitate delirium\"\n            }\n        ],\n        \"monitoring\": [\n            \"Serum calcium and creatinine q12\u202fh during initial therapy\",\n            \"Mental status exam q8\u202fh\",\n            \"Fluid balance and urine output\",\n            \"ECG for QT changes daily\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Geriatric Medicine\",\n                \"urgency\": \"immediate\",\n                \"reason\": \"Comprehensive assessment of functional status, falls risk, and medication review\"\n            },\n            {\n                \"specialty\": \"Endocrinology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Management of hypercalcemia and evaluation for primary hyperparathyroidism\"\n            },\n            {\n                \"specialty\": \"Oncology/Hematology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"Evaluate for multiple myeloma or other malignancy\"\n            },\n            {\n                \"specialty\": \"Psychiatry\",\n                \"urgency\": \"routine\",\n                \"reason\": \"Assess for psychosis, depression, and need for antipsychotic if agitation persists\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Serum calcium >13\u202fmg/dL (risk of cardiac arrhythmia, pancreatitis)\",\n        \"Rapid worsening of mental status or seizure activity\",\n        \"New onset atrial fibrillation or prolonged QT interval\"\n    ],\n    \"patient_education\": [\n        \"Explain that high calcium levels can cause confusion and hallucinations, but they are treatable.\",\n        \"Emphasize importance of hydration and medication adherence to lower calcium.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"Re\u2011evaluate in 48\u202fhours for calcium trend and mental status; outpatient follow\u2011up in 1 week if stable.\",\n        \"conditions\": \"Return immediately if new seizures, severe weakness, chest pain, or worsening confusion.\"\n    },\n    \"confidence_in_assessment\": 0.78,\n    \"uncertainties\": [\n        \"Exact etiology of hypercalcemia (primary hyperparathyroidism vs. malignancy) pending labs\",\n        \"Extent of underlying neurodegenerative disease versus reversible metabolic cause\"\n    ]\n}",
  "latency": 5.471001863479614,
  "timestamp": "2025-08-10T00:25:36.061474",
  "cached_at": "2025-08-10T00:25:36.061478"
}